Vivosim Labs (VIVS) traded flat 0 % during a 24 hours period ending at 01:18 PM Central Europe on Tuesday 27th. One Vivosim Labs stock can currently be bought for about USD 0.15 on popular exchanges. Current supply of Vivosim Labs stocks is 16.6 mn. Vivosim Labs has a current market capitalization of USD 2.4 mn and approximately USD 85 k worth of Vivosim Labs was traded on exchanges in the last 24 hours. Since last month end, Vivosim Labs has traded -31.82 % down. Simple moving average of last 200 days is at USD 1.11. The highest price of past 52 weeks was recorded at USD 3.4 on 01/30/2026. 52 weeks low was at USD 0.14 on 10/26/2026.

Here is how related stocks have performed in the past 24 hours:

  • Volitionrx (VNRX) traded up 5.88 % and now trades at USD 0.18. Volitionrx has a market capitalisation of USD 2.5 mn.

  • Mustang Bio (MBIO) traded down -2.7 % and now trades at USD 0.36. Mustang Bio has a market capitalisation of USD 2.8 mn.

  • Vivos Therapeutics (VVOS) traded down -2.24 % and now trades at USD 0.13. Vivos Therapeutics has a market capitalisation of USD 2.6 mn. Vivos Therapeutics, Inc. filed two Form 4 reports on October 26, 2026, disclosing recent changes in the ownership of its common stock. The filings show that two directors—Lindsay Mark F. and Green Ralph Elias—received new grants of stock options on September 14, 2026. Each grant comprised 12,000 options, with half vesting immediately and the remaining portions scheduled to vest on September 30 and December 31 of that year. The options can be exercised for a decade from the grant date. Following the transactions, each director’s holdings increased to approximately 17,200 shares. The reports confirm that the company’s address remains in Littleton, Colorado, and that the shares were acquired at a price of zero per share, indicating an exercise of the options. No other material corporate actions are noted.

  • Invo Fertility (IVF) traded flat 0 % and now trades at USD 0.57. Current market capitalisation for Invo Fertility is USD 2.8 mn.

About Vivosim Labs

Organovo Holdings, Inc. is a biology company that specializes in bio-printing technology and creating tissues for research and medical applications.